Selective COX-2 inhibitor NSAIDs - Expert Advisory Panel meeting and public forum

Latest updates:

• Health Canada comments on expert panel report, releases COX-2 scientific review (News Release)
• Health Canada Comments on the Report from Expert Advisory Panel on the Safety of COX-2 Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Report on the Cardiovascular Risks Associated with COX-2-Selective Non-Steroidal Anti-Inflammatory Drugs
  
  
• Health Canada responds to Expert Advisory Panel on COX-2 drugs (News Release)
• The Expert Advisory Panel's report to Health Canada

The Expert Advisory Panel met in Ottawa on June 9 and 10, 2005. The first day of the meeting included presentations from Health Canada and several manufacturers of the products and a time set aside for Panel members to hear directly from Canadians. The second day was held in camera for Panel members to deliberate on what they heard and to prepare advice based on the questions posed to them by Heath Canada. The questions related to the safety and efficacy of the products being discussed.

This first public forum was a learning experience for all involved and we welcome your feedback, both on the format for the forum and on this site. If you have any comments, please complete the evaluation form and return it to ocapi-bpcp@hc-sc.gc.ca.

You can view documents and presentations from the event by clicking on the links below.

Please note: Some of the following material originates with an individual or an organization not subject to the Official Languages Act and is available on this site in the language in which it was written. Also, in order to preserve the integrity of this third party information, Health Canada is providing representations of the original presentations in Portable Document Format (PDF) and is not converting these documents to more accessible formats such as HTML. If the following information is not accessible to you, please contact us for assistance.